Within the category of In Vitro Diagnostic (IVD) devices, IVD consumables are projected to experience the highest compound ...

The "A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU (European Union) and UK Training Course (Apr 29, 2026)" training has been added to ResearchAndMarkets.com's ...

At its J.P. Morgan Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that ...

DNV, the independent global assurance and risk management provider, is partnering with Korean AI-driven blood and cancer ...

The "Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests Training Course (May 15, 2026)" has been added to ResearchAndMarkets.com's ...

Great Britain is entering a new era of MedTech regulation, with major pre-market changes expected that are designed to ...

Oxford Nanopore Technologies today announces that the GridIONtm Dx is now both CE and UKCA marked, making it the company's ...

MSMEs need handholding to implement online submission of CDSCO mandated WHO-GMP CoPP: BDMAI: Shardul Nautiyal, Mumbai Monday, January 12, 2026, 08:00 Hrs [IST] Pharma MSMEs need a ...

Oxford Nanopore has reached a major regulatory milestone with the registration of its first In Vitro Diagnostic ("IVD") device in the UK and Europe: the GridION Dx. Oxford Nanopore Technologies today ...

The EU's IVDR provides a regulatory basis for establishing the safety and effectiveness of new in-vitro diagnostic (IVD) ...

EQT Life Sciences is pleased to announce that the LSP Health Economics Fund has exited Vivasure Medical Limited ("Vivasure" or the "Company"), a Galway, Ireland-based company pioneering ...

EST Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures Itasca, IL, US, 12 January 2026 – Biocartis ...